Pharmaceutical Manufacturing Rising to the Challenge of Developing COVID-19 Treatments - ResearchAndMarkets.com

DUBLIN--()--ResearchAndMarkets.com sees Pharmaceutical Manufacturing as a key area experiencing growth due to the Coronavirus pandemic

Drug companies around the world are scrambling, not just to find a vaccine for COVID-19, but to supply drugs that would treat the symptoms. Companies like Eli Lilly, Moderna and Gilead Sciences saw their stocks shoot up once they began working on cures for the pandemic.

ResearchAndMarkets.com offers a variety of research reports covering Pharmaceutical Manufacturing and related topics such as Contract Research Organizations and COVID-19.

Latest available reports on this sector include:

Pharmaceutical Manufacturing is just one area seeing an unexpected rise in demand. ResearchAndMarkets.com have identified the leading trends in the following article: 30 industries seeing a surge in demand due to the COVID-19 pandemic

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

Research and Markets
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900